Trademark Overview
On Wednesday, December 11, 2024, a trademark application was filed for TPDC with the United States Patent and Trademark Office. The USPTO has given the TPDC trademark a serial number of 79420197. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, June 6, 2025. This trademark is owned by ClichemBIO, Inc.. The TPDC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; cardiovascular pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations for treating inflammatory diseases; biological preparations for medical or veterinary purposes; pharmaceutical products, namely, for the prevention and treatment of cancer; pharmaceutical products, namely, for the treatment of inflammatory diseases; pharmaceutical preparations for diagnosis of cancer; pharmaceutical preparations for diagnosis of inflammatory diseases; therapeutic drugs and agents; anti-cancer preparations